The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
Saved in:
| Title: | The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease. |
|---|---|
| Authors: | Younossi, Zobair M.1,2,3 (AUTHOR) zobair.younossi@inova.org, Stepanova, Maria1,2,3,4 (AUTHOR), Felix, Sean1,2,3 (AUTHOR), Jeffers, Thomas1,2,3 (AUTHOR), Younossi, Elena1,2,3 (AUTHOR), Goodman, Zachary1,2,3 (AUTHOR), Racila, Andrei1,2,3 (AUTHOR), Lam, Brian P.1,2,3 (AUTHOR), Henry, Linda1,2,3,4 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Jun2023, Vol. 57 Issue 12, p1417-1422. 6p. 2 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 163949048 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Younossi%2C+Zobair+M%2E%22">Younossi, Zobair M.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> zobair.younossi@inova.org</i><br /><searchLink fieldCode="AR" term="%22Stepanova%2C+Maria%22">Stepanova, Maria</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Felix%2C+Sean%22">Felix, Sean</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jeffers%2C+Thomas%22">Jeffers, Thomas</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Younossi%2C+Elena%22">Younossi, Elena</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goodman%2C+Zachary%22">Goodman, Zachary</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Racila%2C+Andrei%22">Racila, Andrei</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lam%2C+Brian+P%2E%22">Lam, Brian P.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Henry%2C+Linda%22">Henry, Linda</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Alimentary+Pharmacology+%26+Therapeutics%22">Alimentary Pharmacology & Therapeutics</searchLink>. Jun2023, Vol. 57 Issue 12, p1417-1422. 6p. 2 Charts. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=163949048 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/apt.17472 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 1417 Titles: – TitleFull: The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Younossi, Zobair M. – PersonEntity: Name: NameFull: Stepanova, Maria – PersonEntity: Name: NameFull: Felix, Sean – PersonEntity: Name: NameFull: Jeffers, Thomas – PersonEntity: Name: NameFull: Younossi, Elena – PersonEntity: Name: NameFull: Goodman, Zachary – PersonEntity: Name: NameFull: Racila, Andrei – PersonEntity: Name: NameFull: Lam, Brian P. – PersonEntity: Name: NameFull: Henry, Linda IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 06 Text: Jun2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 02692813 Numbering: – Type: volume Value: 57 – Type: issue Value: 12 Titles: – TitleFull: Alimentary Pharmacology & Therapeutics Type: main |
| ResultId | 1 |